Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany

Around 1% of the world’s population is infected with hepatitis C. The introduction of new direct-acting antiviral agents (DAAs) in 2014 has substantially improved hepatitis C treatment outcomes. Our objective was to evaluate the long-term cost effectiveness of DAAs in health care personnel (HP) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Runge, Melanie, Krensel, Magdalene, Westermann, Claudia, Bindl, Dominik, Nagels, Klaus, Augustin, Matthias, Nienhaus, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013637/
https://www.ncbi.nlm.nih.gov/pubmed/31936470
http://dx.doi.org/10.3390/ijerph17020440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013637/
https://www.ncbi.nlm.nih.gov/pubmed/31936470
http://dx.doi.org/10.3390/ijerph17020440

Ejemplares similares